IDEAS home Printed from
   My bibliography  Save this article

Pathways and Policies to (Bio) Pharmaceutical Innovation Systems in Developing Countries


  • Lynn Mytelka


Developing countries have traditionally been regarded as users of technology developed abroad. During the 1980s and 1990s this approach to meeting domestic healthcare needs faced new barriers to consumption and use that resulted from the high cost of drugs and the emergence of new international trade, investment and intellectual property rules. Attention was thus drawn to the possibility of building (bio)pharmaceutical innovation systems at home. By examining the experiences of India, Cuba, Iran, Taiwan, Egypt and Nigeria, this paper identifies a multiplicity of pathways for doing so. Because innovation is embedded in both a policy and institutional context, country-specific triggers and drivers of innovation processes have been important. None the less, some commonalities do appear. Among the more notable triggers were the existence of healthcare crises and earlier incentives that had focused the attention of critical actors on domestic healthcare problems and stimulated a conscious effort by firms to master technology. The interactivity among four types of policies—those strengthening the knowledge base, stimulating capacity building, opening space for local firms and creating incentives for innovation were important in shaping the way these triggers were perceived and in driving the subsequent innovation process.

Suggested Citation

  • Lynn Mytelka, 2006. "Pathways and Policies to (Bio) Pharmaceutical Innovation Systems in Developing Countries," Industry and Innovation, Taylor & Francis Journals, vol. 13(4), pages 415-435.
  • Handle: RePEc:taf:indinn:v:13:y:2006:i:4:p:415-435
    DOI: 10.1080/13662710601032770

    Download full text from publisher

    File URL:
    Download Restriction: Access to full text is restricted to subscribers.

    As the access to this document is restricted, you may want to search for a different version of it.


    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.

    Cited by:

    1. Engel, Nora, 2008. "Drivers and Barriers of Innovation Dynamics in Healthcare - Towards a framework for analyzing innovation in Tuberculosis control in India," MERIT Working Papers 077, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).


    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:taf:indinn:v:13:y:2006:i:4:p:415-435. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Chris Longhurst). General contact details of provider: .

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.